Drug Trial Radar · NCT02651714
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Jun 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
168
Actual
Start
Jan 19, 2016
Primary completion
Aug 4, 2017
Study completion Aug 4, 2017
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 11, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
TradipitantDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Pruritus Symptoms, as Measured by the 24-hour Average Pruritus Visual Analogue Scale (VAS) ScoreTime frame: 56 days
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Encinitas, California
Vanda Investigational Site
Encino, California
Vanda Investigational Site
Lomita, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
Miami, Florida
Vanda Investigational Site
Miami, Florida
Vanda Investigational Site
Ormond Beach, Florida
Vanda Investigational Site
Columbus, Georgia
Vanda Investigational Site
Plainfield, Indiana
Vanda Investigational Site
Crowley, Louisiana
Vanda Investigational Site
St Louis, Missouri
Vanda Investigational Site
Las Vegas, Nevada
Vanda Investigational Site
New York, New York
Vanda Investigational Site
New York, New York
Vanda Investigational Site
High Point, North Carolina
Vanda Investigational Site
Wilmington, North Carolina
Vanda Investigational Site
Winston-Salem, North Carolina
Vanda Investigational Site
Portland, Oregon
Vanda Investigational Site
Philadelphia, Pennsylvania
Vanda Investigational Site
Johnston, Rhode Island
Vanda Investigational Site
Charleston, South Carolina
Vanda Investigational Site
Houston, Texas
Vanda Investigational Site
Pflugerville, Texas
Vanda Investigational Site
San Antonio, Texas
Vanda Investigational Site
West Jordan, Utah
Vanda Investigational Site
Seattle, Washington
Vanda Investigational Site
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.